Total Number of Communication Reports: 0
Monthly communication reports in the last 6 months: 0
Subject matters | Details | Categories |
---|---|---|
Government Procurement, Health
|
To discuss the successful execution of existing and future vaccine procurements and the successful launch of the Moderna Laval facility. Also identifying opportunities to increase biomanufacturing capabilities in Canada.
|
Government Contract Pursued
|
End date of the last completed financial year: 2023-12-31
Government Institution | Funding Received in Last Financial Year | Funding Expected in Current Financial Year |
---|---|---|
Investissement Quebec | $0.00 | Yes |
Ministry of Economic Development, Job Creation and Trade Ontario | $0.00 | Yes |
Address:
155 Wellington St W
Suite 3130
Toronto, ON M5V 3H1
Canada
Telephone number:
514-465-4894
Web address:
www.modernatx.com
Stefan Raos, General Manager
Moderna Biopharma Canada Corporation is not a coalition.
The activities of Moderna Biopharma Canada Corporation are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking.
Matthew Gagne | No public offices held
Firm: McMillan Vantage